NFL BIOSCIENCES (EPA:ALNFL) | Finanzwire

Basculer en Français

8205	Companies
109402	Keywords
51585	Articles
60264	Press releases

Home
Companies
NFL BIOSCIENCES

REGULATED PRESS RELEASE

published on 02/13/2024 at 17:45, 8 months 20 days ago

NFL BIOSCIENCES WILL PRESENT THE RESULTS OF THE PRECESTO CLINICAL STUDY AT THE SRNT CONFERENCE, THE WORLD'S LEADING SCIENTIFIC SOCIETY IN THE FIELD OF NICOTINE AND TOBACCO RESEARCH
NFL Biosciences to present promising results of the PRECESTO clinical study at the SRNT Conference, focusing on smoking cessation with botanical drug NFL-101. Phase 2b trial ongoing for CESTO 2

NFL Biosciences Smoking Cessation NFL-101 PRECESTO Study CESTO 2
REGULATED PRESS RELEASE

published on 01/30/2024 at 08:00, 9 months 5 days ago

NFL BIOSCIENCES: SUCCESS OF THE STUDY WITH THE CEA
NFL BIOSCIENCES announces the successful study with the CEA demonstrating a new mechanism of action for smoking cessation using NFL-101, a botanical drug. Results open new possibilities for addiction treatment

NFL Biosciences Addiction Treatment CEA Study Smoking Cessation NFL-101
REGULATED PRESS RELEASE

published on 01/09/2024 at 17:45, 9 months 26 days ago

NFL BIOSCIENCES: FINANCIAL CALENDAR FOR 2024
NFL Biosciences, a biopharmaceutical company, has announced its financial communication calendar for 2024, including dates for annual results, Annual General Meeting, and half-year results. The company is known for developing botanical drug candidates for the treatment of addictions, such as NFL-101 for nicotine cessation and NFL-301 for reducing alcohol consumption. For more information, visit www.nflbiosciences.com.

NFL Biosciences Biopharmaceutical Company Financial Calendar 2024 Botanical Drug Candidates Addiction Treatment
REGULATED PRESS RELEASE

published on 12/19/2023 at 08:00, 10 months 16 days ago

NFL BIOSCIENCES: PRE-IND APPLICATION FILED WITH THE FDA IN THE UNITED STATES FOR NFL-301, INDICATED FOR REDUCING ALCOHOL CONSUMPTION
REGULATED PRESS RELEASE

published on 10/05/2023 at 19:00, 1 year ago

NFL BIOSCIENCES: 2023 FIRST-HALF BUSINESS AND EARNINGS UPDATE

Accesswire

Published on 11/04/2024 at 22:10, 15 minutes ago

Gladstone Commercial Corporation Reports Results for the Third Quarter Ended September 30, 2024
Published on 11/04/2024 at 22:01, 24 minutes ago

Amdocs Releases First Quarter Fiscal 2025 Investor Conference Schedule
Published on 11/04/2024 at 22:00, 25 minutes ago

Tectonic Metals Surpasses C$5M In Capital Raised With Oversubscribed Private Placement To Advance Flat Gold Project
Published on 11/04/2024 at 21:45, 40 minutes ago

Hank Payments Responds to Press Release Issued By Melrose Ventures
Published on 11/04/2024 at 21:30, 55 minutes ago

Forward Water Technologies Corp. Announces Shares for Interest Debt Settlement

View all ACCESSWIRE

EQS Group

Published on 11/04/2024 at 21:15, 1 hour 9 minutes ago

EQS-Adhoc: LEG Immobilien SE: Acquisition of Brack Capital Properties N.V. through the conclusion of a share purchase agreement and a tender commitment in the event of a public offer
Published on 11/04/2024 at 19:00, 3 hours 24 minutes ago

EQS-Adhoc: Salzgitter Aktiengesellschaft: Potential voluntary public takeover bid to the shareholders of Salzgitter AG
Published on 11/04/2024 at 18:47, 3 hours 37 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/04/2024 at 18:18, 4 hours 7 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/04/2024 at 18:09, 4 hours 15 minutes ago

EQS-Adhoc: infas Holding Aktiengesellschaft: Further examination of the ongoing public takeover offer by the Federal Cartel Office

Les Echos

Published on 11/04/2024 at 18:13, 4 hours 11 minutes ago

Thales: Launch of the 2024 Employee Share Ownership Plan
Published on 11/04/2024 at 18:11, 4 hours 13 minutes ago

Monthly disclosure of the total number of shares and voting rights - 31/10/2024
Published on 11/04/2024 at 17:45, 4 hours 40 minutes ago

Disclosure of trading in own shares from October 29th, 2024, to November 1st, 2024. Detailed information per transaction.
Published on 11/04/2024 at 17:45, 4 hours 40 minutes ago

Disclosure of trading in own shares from October 29th, 2024, to November 1st, 2024
Published on 11/04/2024 at 17:31, 4 hours 53 minutes ago

Statement of transactions in own shares from October 28, 2024 to November 1, 2024

View all LES ECHOS COMFI WIRE